Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Sorrentino

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Mechanisms of Ageing and Development|November 1, 1984
Structural comparisons of fibronectins isolated from early and late passage cellsJ A Sorrentino, A J Millis
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Interaction of fibronectin with collagen: age-specific defect in the biological activity of human fibroblast fibronectinS Chandrasekhar, J A Sorrentino, A J Millis
Experimental Cell Research|May 1, 1983
Lymphoblastoid cell variant in contact-mediated cell spreadingJ A Sorrentino, A J Millis, A P Whipple, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Mechanisms of Ageing and Development|November 1, 1984
Structural comparisons of fibronectins isolated from early and late passage cellsJ A Sorrentino, A J Millis
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Interaction of fibronectin with collagen: age-specific defect in the biological activity of human fibroblast fibronectinS Chandrasekhar, J A Sorrentino, A J Millis
Experimental Cell Research|May 1, 1983
Lymphoblastoid cell variant in contact-mediated cell spreadingJ A Sorrentino, A J Millis, A P Whipple, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.
Pageof 1